| *Sponsored
(NYSE American: NNVC) Shares Key Announcement This Morning (Multiple Technicals Triggered)
May 22nd Greetings, Friend!
NanoViricides, Inc. (NYSE American: NNVC) continues to hold the top spot on my watchlist early Thursday for multiple reasons.
First off, the company shared a key announcement this morning.
Check it out here: The New Rational FDA CVD Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan
From the article:
"Evidence-based decision making about vaccine boosters policy for CVD is a welcome change over broadcast vaccine recommendation for all," commented Anil R. Diwan, Ph.D., President and Executive Chairman of NanoViricides, adding, "This rational and scientific, non-dogmatic approach should go a long way towards restoring public trust in institutions that make decisions that affect peoples' lives."
On top of the news, NNVC continues to have 8 triggered technical indicators over at Barchart including the website's composite "Trend Seeker" indicator.
Plus, with a low float of fewer than 16Mn shares, volatility potential could be heightened on a daily basis.
Take a moment to read my initial report quickly and then consider (NYSE American: NNVC) for your radar. -----
We're watching a potential breakout idea currently flying under-the-radar on the NYSE American.
So, what's special about this one?
First off, they are a cutting-edge biopharmaceutical company who has just completed a successful Phase I clinical trial for its innovative broad-spectrum antiviral, NV-387, with no adverse events reported, raising hopes for a new era in combating viral pandemics.
They're also strategically advancing NV-387 into Phase II trials targeting M-P-ox in Central Africa, while also preparing for future studies against influenza, RSV, and other high-impact viral threats.
With a robust intellectual property portfolio and a unique technology platform, this enterprise is positioning itself at the forefront of antiviral innovation—leaving the world to wonder what breakthrough will come next.
And registering fewer than 16Mn shares in its float, volatility potential could be extremely present for this profile on a daily basis.
With an aim to disrupt multiple, Bn dollar markets, this company has eluded Wall Street's attention for the time being.
But for how much longer, that's tough to say.
As this company powers forward in 2025 and beyond, it may just be a matter of time until they become a household name as global health uncertainties could propel their game-changing work into the spotlight.
Hitting #1 on my watchlist this week, it may be time to consider this breakout idea for your radar:
*NanoViricides, Inc. (NYSE American: NNVC)*
NanoViricides, Inc. is a global leader in the development of nanomedicine drugs.
Their unique nanoviricide® platform technology defines a novel mechanism enabling first-in class drugs against vir-uses.
A nanoviricide is designed to specifically attack enveloped vir-us particles, on the same sites that they use to bind to cells, and dismantle them, blocking reinfection cycle, going beyond what antibodies and immunotherapeutics do.
It can also be designed to deliver anti-viral payload into infected cells sparing uninfected cells to block replication cycle without toxicity.
The company's unique biomimetic approach enables creation of drugs that a vir-us would be highly unlikely to escape due to mutations.
NanoViricides is one of the few biopharma companies with its own multi-kilogram-scale c-GMP capable manufacturing facility for the drug substance as well as drug product.
This facility is fully owned by the Company with no mortgage and is a major asset.
This flexible, multi-product pilot plant can supply drug product for all of their programs through human clinical trials.
Their cGMP manufacturing ability enables substantial time and cost savings in their drug development programs.
Further, it is capable of production for initial marketing, enabling early revenues upon drug approval, of about $100Mn~$500Mn per year.
Company Sources: Presentation. Website. | 
0 Response to "(NYSE American: NNVC) Shares Key Announcement This Morning (Multiple Technicals Triggered)"
Post a Comment